Celltrion
068270.KS
$128.28
Share price
-0.45%
Change (1 day)
3.37%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
EPS for Celltrion (068270.KS)
EPS in 2023 (TTM): $2.99
According to Celltrion 's latest financial reports the company's current EPS (TTM) is $2.99. In 2022 the company made an earnings per share (EPS) of $2.91 a decrease over its 2021 EPS that were of $3.46.
EPS history for Celltrion from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.99 | 2.72% |
| 2022 | $2.91 | -15.84% |
| 2021 | $3.46 | 12.77% |
| 2020 | $3.07 | 70.79% |
| 2019 | $1.80 | 15.63% |
| 2018 | $1.55 | -33.13% |
| 2017 | $2.32 | 141.17% |
| 2016 | $0.96 | 8.28% |
| 2015 | $0.89 | 11.28% |
| 2014 | $0.80 | 16.37% |
| 2013 | $0.69 | -67.42% |
| 2012 | $2.11 | 84.22% |
| 2011 | $1.14 | 62.13% |
| 2010 | $0.71 | 80.61% |
| 2009 | $0.39 | -559.63% |
| 2008 | -$0.08503 | -123.16% |
| 2007 | $0.37 |